Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

C-peptide - Creative Peptides

Drug Profile

C-peptide - Creative Peptides

Alternative Names: C-peptide; SPM 933

Latest Information Update: 01 Sep 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Creative Peptides
  • Class Pancreatic hormones
  • Mechanism of Action Adenosine triphosphatase stimulants; Nitric oxide synthase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Diabetic nephropathies; Diabetic neuropathies

Most Recent Events

  • 28 Feb 2001 Discontinued-II for Diabetic nephropathies in Germany (SC)
  • 28 Feb 2001 Discontinued-II for Diabetic neuropathies in Germany (SC)
  • 06 Mar 2000 Predicted peak sales have been added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top